“…Metabolic changes observed in AD patients and AD models include glucose breakdown and pyruvate oxidation [79], impairment of protein synthesis in early-stage AD [80], increased levels of some amino acids, serotonin, catecholamine and Krebs cycle metabolites [79,81,82], alterations in purine metabolic pathways [79,81], imbalanced cholesterol [83] and sphingolipid [84] homeostasis, large networkwide disruptions in ceramide and phosphoinositide biosynthesis and signaling [85], disruptions in the cellular systems for handling (uptake, intracellular transport, protein loading and storage) transition metals [86,87], dysregulated one-carbon metabolism [88] and some others.…”